参考文献/References:
[1]Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020: GLOBOCANestimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.[2]Chen WQ,Zheng RS,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.[3]Lehmann BD,Bauer JA,Chen X,et al.Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies[J].J Clin Invest,2011,121(7):2750-2767.[4]Burstein MD,Tsimelzon A,Poage GM,et al.Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer[J].Clin Cancer Res,2015,21(7):1688-1698.[5]Low SK,Zembutsu H,Nakamura Y.Breast cancer: The translation of big genomic data to cancer precision medicine[J].Cancer Sci,2018,109(3):497-506.[6]Stockwell BR,FriedmannAngeli JP,Bayir H,et al.Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease[J].Cell,2017,171(2):273-285.[7]Dixon SJ,Stockwell BR.The role of iron and reactive oxygen species in cell death[J].Nat Chem Biol,2014,10(1):9-17.[8]Bi JL,Yang SJ,Li L,et al.Metadherin enhances vulnerability of cancer cells to ferroptosis[J].Cell Death Dis,2019,10(10):682-693.[9]Liu T,Jiang L,Tavana O,et al.The deubiquitylase OTUB1 mediates ferroptosis via stabilization of SLC7A11[J].Cancer Res,2019,79(8):1913-1924.[10]Ubellacker JM,Tasdogan A,Ramesh V,et al.Lymph protects metastasizing melanoma cells from ferroptosis [J].Nature,2020,585(7823):113-118.[11]Ou W,Anwar A,Mulik R,et al.Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma[J].Free Radic Biol Med,2017(112):597-607.[12]Hassannia B,Vandenabeele P,VandenBerghe T.Targeting ferroptosis to iron out cancer[J].Cancer Cell,2019,35(6):830-849.[13]Dixon S,Lemberg K,Lamprecht M,et al.Ferroptosis: an iron-dependent form of nonapoptotic cell death [J].Cell,2012,149(5):1060-1072.[14]Battaglia AM,Chirillo R,Aversa I,et al.Ferroptosis and cancer: mitochondria meet the "Iron Maiden" cell death[J].Cells,2020,9(6):1505-1530.[15]Mou YH,Wang J,Wu JC,et al.Ferroptosis, a new form of cell death: opportunities and challenges in cancer[J].J Hematol Oncol,2019,12(1):34-39.[16]Torii S,Shintoku R,Kubota C,et al.An essential role for functional lysosomes in ferroptosis of cancer cells[J].Biochem J,2016,473(6):769-777.[17]Li Y,Feng DC,Wang ZY,et al.Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion[J].Cell Death Differ,2019,26(11):2284-2299.[18]Belaidi AA,Bush AI.Iron neurochemistry in Alzheimer’s disease and Parkinson’s disease: Targets for therapeutics[J].J Neurochem,2016,139(Suppl 1):179-197.[19]Ma S,Henson ES,Chen Y,et al.Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells[J].Cell Death Dis,2016,7(7):e2307.[20]Ooko E,Saeed MEM,Kadioglu O,et al.Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells[J].Phytomedicine,2015,22(11):1045-1054.[21]Qiu YM,Cao Y,Cao WJ,et al.The application of ferroptosis in diseases[J].Pharmacol Res,2020(159):104919.[22]Wu G,Fang YZ,Yang S,et al.Glutathione metabolism and its implications forhealth[J].J Nutr,2004,134(3):489-492.[23]Lu SC.Regulation of glutathione synthesis[J].Mol Aspects Med,2009,30(1-2):42-59.[24]Hatem E,El Banna N,Huang ME.Multifaceted roles of glutathione and glutathione-basedsystems in carcinogenesis and anticancer drug resistance[J].Antioxid Redox Signal,2017,27(15):1217-1234.[25]Ingold I,Berndt C,Schmitt S,et al.Selenium utilization by GPX4 Is required to prevent hydroperoxide-induced ferroptosis[J].Cell,2018,172(3):409-422.[26]Ursini F,Maiorino M,Brigelius-Flohe R,et al.Diversity of glutathione peroxidases[J].Methods Enzymol,1995(252):38-53.[27]Seiler A,Schneider M,Forster H,et al.Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-Mediated cell death[J].Cell metabolism,2008,8(3):237-248.[28]Yang WS,SriRamaratnam R,Welsch ME,et al.Regulation of ferroptoticcancercell death by GPX4[J].Cell,2014,156(1-2):317-331.[29]Wang LY,Liu YC,Du TT,et al.ATF3 promotes erastin-induced ferroptosis by suppressing system Xc[J].Cell Death Differ,2020,27(2):662-675.[30]Sui XB,Zhang RN,Liu SP,et al.RSL3 Drives Ferroptosis Through GPX4 inactivation and ROS production in colorectal cancer[J].Front Pharmacol,2018(9):1371-1378.[31]Shen Z,Song J,Yung BC,et al.Emerging strategies of cancer therapy based on ferroptosis[J].Adv Mater,2018,30(12):e1704007.[32]Xu T,Ding W,Ji XY,et al.Molecular mechanisms of ferroptosis and its role in cancer therapy[J].J Cell Mol Med,2019,23(8):4900-4912.[33]步宏,李一雷.病理学[M].第九版.北京:人民卫生出版社,2018:103-106.[34]Urooj T,Wasim B,Mushtaq S,et al.Cancer cell-derived secretory factors in breast cancer-associated lung metastasis: their mechanism and future prospects[J].Curr Cancer Drug Targets,2020,20(3):168-186.[35]DeSantis CE,Ma J,Gaudet MM,et al.Breast cancer statistics,2019[J].CA Cancer J Clin,2019,69(6):438-451.[36]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.[37]Lin YS,Shen YC,Wu CY,et al.Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells[J]. Front Pharmacol,2019(10):1226-1238.[38]Yu HC,Yang CC,Jian L,et al.Sulfasalazine-induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor[J].Oncol Rep,2019,42(2):826-838.[39]Chen MS,Wang SF,Hsu CY,et al.CHAC1 degradation of glutathione enhances cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-eIF2alpha-ATF4 pathway[J].Oncotarget,2017,8(70):114588-114602.[40]Lee N,Carlisle AE,Peppers A,et al.xCT-driven expression of GPX4 determines sensitivity of breast cancer cells to ferroptosisinducers[J].Antioxidants (Basel),2021,10(2):317-328.[41]Hasegawa M,Takahashi H,Rajabi H,et al.Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells[J].Oncotarget,2016,7(11):11756-11769.[42]Yadav P,Sharma P,Sundaram S,et al.SLC7A11/xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells[J].Cancer Lett,2021(522):211-224.[43]Sun D,Li YC,Zhang XY.Lidocaine Promoted Ferroptosis by Targeting miR-382-5p /SLC7A11 Axis in Ovarian and Breast Cancer[J].Front Pharmacol,2021(12):681223-681232.[44]Hou YF,Cai S,Yu SY,et al.Metformin induces ferroptosis by targeting miR-324-3p/GPX4 axis in breast cancer[J].Acta Biochim Biophys Sin (Shanghai),2021,53(3):333-341.[45]Zhang HM,Ge ZC,Wang ZH,et al.Circular RNA RHOT1 promotes progression and inhibits ferroptosis via mir-106a-5p/STAT3 axis in breast cancer[J].Aging (Albany NY),2021,13(6):8115-8126.[46]Wu XH,Liu CL,Li ZHR,et al.Regulation of GSK3beta/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer[J].Mol Cell Biochem,2020,473(1-2):217-228.[47]Luis G,Godfroid A,Nishiumi S,et al.Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence[J].Redox Biol,2021,43(2021):102006-102022.[48]Yi JM,Zhu JJ,Wu J,et al.Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis [J].Proc Natl Acad Sci U S A,2020,117(49):31189-31197.[49]Lin CC,Yang WH,Lin YT,et al.DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway[J].Oncogene,2021,40(11):2018-2034.[50]Dinarvand N,Khanahmad H,Hakimian SM,et al.Evaluation of long-chain acyl-coenzyme A synthetase 4 (ACSL4) expression in human breast cancer[J].Res Pharm Sci,2020,15(1):48-56.[51]Sha R,Xu YQ,Yuan CW,et al.Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvantchemotherapy[J].EBio Medicine,2021(71):103560-103576.[52]Zhou YL,Yang JJ,Chen C,et al.Polyphyllin -Induced Ferroptosis in MDA-MB-231 Triple-Negative Breast Cancer Cells can Be Protected Against by KLF4-Mediated Upregulation of xCT[J].Front Pharmacol,2021(12):670224-670237.[53]Kang R,Kroemer G,Tang D.The tumor suppressor protein p53 and the ferroptosisnetwork[J].Free Radic Biol Med,2019(133):162-168.[54]Zhang Z,Lu ML,Chen CL,et al.Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer[J].Theranostics,2021,11(7):3167-3182.[55]Karmi O,Sohn YS,Zandalinas SI,et al.Disrupting CISD2 function in cancer cells primarily impacts mitochondrial labile iron levels and triggers TXNIP expression[J].Free Radic Biol Med,2021(176):92-104.[56]Tang MZ,Chen Z,Wu D,et al.Ferritinophagy/ferroptosis: Iron-related newcomers in human diseases[J].J Cell Physiol,2018,233(12):9179-9190.[57]Anastasiadi Z,Lianos GD,Ignatiadou E,et al.Breast cancer in young women: an overview[J].Updates Surg,2017,69(3):313-317.[58]Chen LY,Li XX,Liu LB,et al.Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-gamma-lyasefunction[J].Oncol Rep,2015,33(3):1465-1474.[59]Yamaguchi H,Hsu JL,Chen CT,et al.Caspase-independent cell death is involved in the negative effect of EGF receptor inhibitors on cisplatin in non-small cell lung cancer cells[J].ClinCancer Res,2013,19(4):845-854.[60]Doll S,Conrad M.Iron and ferroptosis: a still ill-defined liaison [J].IUBMB Life,2017,69(6):423-434.[61]Li ZHR,Wu XH,Wang WY,et al.Fe(II) and Tannic Acid-Cloaked MOF as Carrier of Artemisinin for Supply of Ferrous Ions to Enhance Treatment of Triple-Negative Breast Cancer[J].Nanoscale Res Lett,2021,16(1):37-47.[62]Zhu JD,Dai PP,Liu F,et al.UpconvertingNanocarriers Enable Triggered Microtubule Inhibition and Concurrent Ferroptosis Induction for Selective Treatment of Triple-Negative Breast Cancer[J].Nano Lett,2020,20(9):6235-6245.[63]Li RH,Zhang J,Zhou YF,et al.Transcriptome Investigation and In Vitro Verification of Curcumin-Induced HO-1 as a Feature of Ferroptosis in Breast Cancer Cells[J].Oxid Med Cell Longev,2020(2020):3469840-3469857.[64]Yang J,Zhou Y,Xie S,et al.Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer[J].J Exp Clin Cancer Res,2021,40(1):206-224.[65]Du JJ,Wang LS,Huang XM,et al.Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells[J].Phytomedicine,2021(85):153551.[66]Kato I,Kasukabe T,Kumakura S.Menin-MLL inhibitors induce ferroptosis and enhance the anti-proliferative activity of auranofin in several types of cancer cells[J].Int J Oncol,2020,57(4):1057-1071.[67]Zhao Y,Zhao W,Lim YC,et al.Salinomycin-loaded gold nanoparticles for treating cancer stem cells by ferroptosis-induced cell death[J].Mol Pharm,2019,16(6):2532-2539.[68]Taylor WR,Fedorka SR,Gad I,et al.Small-molecule ferroptoticagents with potential to selectively target cancer stem cells[J].Sci Rep,2019,9(1):5926-5939.[69]Nagpal A,Redvers RP,Ling X,et al.Neoadjuvantneratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2(+ve) breast cancer metastasis[J]. Breast Cancer Res,2019,21(1):94-102.
相似文献/References:
[1]董 云.SPECT/CT 双时相99mTc- MIBI断层显像
在乳腺癌诊断中的应用[J].医学信息,2018,31(05):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
DONG Yun.Application of SPECT/CT Dual-phase 99mTc-MIBI Tomography in the Diagnosis of Breast Cancer[J].Medical Information,2018,31(05):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
[2]张 虎,张 涛,徐 芳,等.MRI在乳腺癌诊治中的研究进展[J].医学信息,2022,35(10):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
ZHANG Hu,ZHANG Tao,XU Fang,et al.Research Progress of MRI in Diagnosis and Treatment of Breast Cancer[J].Medical Information,2022,35(05):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
[3]李建辉,祝旭龙.乳腺癌的治疗管理——把好生活质量关[J].医学信息,2018,31(13):1.[doi:10.3969/j.issn.1006-1959.2018.13.001]
[4]杨玉峰,李 强,曲国红,等.乳腺癌术前巴德枪穿刺检测ER、PR的临床研究[J].医学信息,2018,31(13):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
YANG Yu-feng,LI Qiang,QU Guo-hong,et al.Clinical Study on Preoperative ER and PR Detection of Bard Gun Puncture in Breast Cancer[J].Medical Information,2018,31(05):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
[5]刘雪静,路 红,徐熠琳,等.乳腺影像与容积导航技术初步应用的临床分析[J].医学信息,2022,35(11):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
LIU Xue-jing,LU Hong,XU Yi-lin,et al.Clinical Analysis of the Preliminary Application of Breast Imaging and Volume Navigation Technology[J].Medical Information,2022,35(05):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
[6]刘在波,修文娟.背阔肌皮瓣联合假体在乳腺癌改良根治术后乳房重建中的应用[J].医学信息,2019,32(02):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
LIU Zai-bo,XIU Wen-juan.Application of Latissimus Dorsi Flap Combined with Prosthesis in Breast Reconstruction after Modified Radical Mastectomy for Breast Cancer[J].Medical Information,2019,32(05):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
[7]孟庆国,王佳雪,王斯佳.马来酸吡咯替尼对乳腺癌术后患者心脏功能的影响[J].医学信息,2019,32(02):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
MENG Qing-guo,WANG Jia-xue,WANG Si-jia.Effect of Pyrrolidine Maleate on Cardiac Function in Patients after Breast Cancer Operation[J].Medical Information,2019,32(05):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
[8]刘 曼,厉玛倩倩,徐润润,等.延续性护理对乳腺癌术后化疗患者生活质量与
健康知识水平的影响[J].医学信息,2018,31(16):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
LIU Man,LIMA Qian-qian,XU Run-run,et al.Effect of Continuous Nursing on Quality of Life and Health Knowledge of Postoperative Chemotherapy Patients with Breast Cancer[J].Medical Information,2018,31(05):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
[9]满枋霖,葛俊宏,林晓月,等.p21活化激酶在乳腺癌中的作用研究[J].医学信息,2019,32(06):35.[doi:10.3969/j.issn.1006-1959.2019.06.013]
MAN Fang-lin,GE Jun-hong,LIN Xiao-yue,et al.The Role of p21 Activated Kinase in Breast Cancer[J].Medical Information,2019,32(05):35.[doi:10.3969/j.issn.1006-1959.2019.06.013]
[10]张天竺,宁 勇.长链非编码RNA调控乳腺癌发生发展的研究进展[J].医学信息,2019,32(12):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]
ZHANG Tian-zhu,NING Yong.Advances in Research on Long-chain Non-coding RNA Regulation of Breast Cancer Development[J].Medical Information,2019,32(05):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]